IDH1 mutations occur less frequently than IDH2 in total AML population (7.7% for IDH1 vs 15.4% for IDH2) and lead to a substitution of arginine 132 for either histidine or cysteine (R132H and R132C)4. This evidence concerns the gene IDH2 and acute myeloid leukemia.